Smart scans may guide better esophageal cancer therapy

NCT ID NCT07385664

First seen Feb 04, 2026 · Last updated Apr 24, 2026 · Updated 11 times

Summary

This study tests whether a special PET scan (FAPI-PET/CT) can help doctors choose the best next treatment for people with esophageal cancer after initial chemotherapy and immunotherapy. About 66 adults with resectable esophageal cancer will receive chemoimmunotherapy, then a scan to see how well the tumor responded. Those with a good response continue chemoimmunotherapy; those with a poor response switch to chemoradiotherapy. The goal is to improve the chance of a complete response (no cancer left at surgery) while reducing unnecessary side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESECTABLE ESOPHAGEAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, 310022, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.